Novodiax, Inc.

Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly sensitive polymer conjugates that are organized into three product categories: ihcDirect, ihcPrime, and Q-STAIN X. These product lines address unmet needs over a wide range of applications and markets including rapid intraoperative tests for surgical oncologists, novel development of companion diagnostics, increased throughput in drug discovery, and improved sensitivity across all IHC applications. ihcDirect is a revolutionary IHC technology (patent pending) further advanced from our polymer detection systems. Some of the most commonly utilized diagnostic antibodies are directly conjugated to our polyHRP, resulting in a simpler and faster IHC procedure that minimizes intermediate steps.